Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study

Lancet

Volumn 353, Issue 9170, 1999, Pages 2105-2110

  Rothwell, P M ^a   Warlow, C P ^b  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; HIGH RISK PATIENT; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STROKE; SURGICAL MORTALITY;

EID: 0033583959     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)11415-0     Document Type: Article

References (29)

1. Howard V.J., Grizzle J., Diener H.C.et al. Comparison of multicentre study designs for investigation of carotid endarterectomy efficacy. Stroke. 23:1992;583-593.
2. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 337:1991;1235-1243.
3. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 325:1991;445-453.
4. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 351:1998;1379-1387.
5. The final results of the NASCET trial. N Engl J Med. 339:1998;1415-1425.
6. Barnett H.J.M., Warlow C.P. Carotid endarterectomy and the measurement of stenosis. Stroke. 24:1993;1281-1284.
7. Rothwell P.M., Gibson R.J., Slattery J., Sellar R.J., Warlow C.P. Equivalence of measurements of carotid stenosis: a comparison of three methods on 1001 angiograms. Stroke. 25:1994;2435-2439.
8. Rothwell P.M., Slattery J., Warlow C.P. A systematic review of the risks of stroke and death due to carotid endarterectomy for symptomatic stenosis. Stroke. 27:1996;260-265.
9. Hankey G.J., Slattery J.M., Warlow C.P. Transient ischaemic attacks: which patients are at high (and low) risks of serious vascular events? J Neurol Neurosurg Psychiatry. 55:1992;640-652.
10. Howard G., Toole J.F., Frye-Pierson J., Hinshelwood L.C. Factors influencing the survival of 451 transient ischaemic attack patients. Stroke. 18:1987;522-557.
11. Dutch T.I.A. Trial Study Group. Predictors of major vascular events in patients with a transient ischaemic attack or nondisabling stroke. Stroke. 24:1993;527-531.
12. Steifler J.Y., Elisaziw M., Benavente O.R.et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient attacks and high-grade carotid stenosis. Arch Neurol. 52:1995;246-249.
13. Rothwell P.M., Villagra R., Donders R., Warlow C.P. Ocular vs cerebral transient ischaemic attacks: distinctly different disorders. Cerebrovasc Dis. 7(4):1997;17. (abstr).
14. Eliasziw M., Streifler J.Y., Fox A.J.et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. Stroke. 25:1994;304-308.
15. Rothwell P.M., Villagra R., Donders R., Warlow C.P. The role of carotid atherosclerosis in the aetiology of ischaemic troke. Cerebrovasc Dis. 6(2):1996;1. (abstr).
16. Rothwell P.M., Slattery J., Warlow C.P. A systematic review of clinical and angiographic predictors of stroke and death due to carotid endarterectomy. BMJ. 315:1997;1571-1577.
17. Rothwell P.M., Slattery J., Warlow C.P. Can we identify the patients with the least to lose and the most to gain from endarterectomy? Cerebrovasc Dis. 4(1):1994;260. (abstr).
18. Rothwell P.M. Can overall results of clinical trials be applied to all patients? Lancet. 345:1995;1616-1619.
19. Endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 351:1998;1379-1387.
20. Lambert M. Should carotid endarterectomy by purchased? Purchasers need a broader perspective. BMJ. 310:1995;317-318.
21. Concato J., Feinstein A.R., Holford T.R. The risk of determining risk with multivariable models. Ann Intern Med. 118:1993;201-210.
22. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med (in press).
23. Peduzzi P., Concato J., Kemper E., Holford T.R., Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 49:1996;1373-1379.
24. Morgenstern L.B., Fox A.J., Sharpe B.L., Eliasziw M., Barnett H.J.M., Grotta J.C. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. Neurology. 48:1997;911-915.
25. Davey Smith G., Egger M. Who benefits from medical interventions? Treating low risk patients can be a high risk strategy. BMJ. 308:1994;72-74.
26. Hoes A.W., Grobbee D.E., Lubsen J. Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens. 13:1995;805-811.
27. Rothwell P.M., Warlow C.P Management of transient ischaemic attacks: from clinical trials to individual patients. Farthing M.J.G. Horizons in medicine. 1997;Royal College of Physicians, London.
28. Sharp S.J., Thompson S.G., Altman D.G. The relation between treatment benefit and underlying risk in meta-analysis. BMJ. 313:1996;735-738.
29. Yusuf S., Zuker D., Peduzzi P.et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 344:1994;563-570.